Back to search results

Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis

Abroad (travel likely)RecruitingPHASE3

Conditions

Post-ERCP Acute Pancreatitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Johns Hopkins Hospital, Baltimore, Maryland, United States

    Contact: Study coordinator (Venkata S Akshintala, M.D.) · vakshin1@jhmi.edu · 410-624-6955

  • Asian Institute of Gastroenterology, Hyderabad, Andhra Pradesh, India

    Contact: Study coordinator (Sundeep Lakhtakia, MD, DM) · drsundeeplakhtakia@gmail.com

  • Apollo Multispecialty Hospitals,, Kolkata, West Bengal, India

    Contact: Study coordinator (Mahesh K Goenka, MD, DM) · mkgkolkata@gmail.com

  • Post Graduate Institute of Medical Education and Research, Chandigarh, India

    Contact: Study coordinator (Saroj K, Sinha) · sarojksinha@hotmail.com

  • Singapore General Hospital, Singapore, Singapore

    Contact: Study coordinator (Clement CH Wu) · clement.wu.c.h@singhealth.com.sg
Study leads

  • Venkata S. Akshintala, M.D.

    Principal Investigator

    Johns Hopkins University

View source on ClinicalTrials.gov(opens in a new tab)